Cardionovum

Be up
to date.

Latest press release

RESTORE® Drug-Coated Balloon receives first Chinese FDA medical device registration certificate for two indications

RESTORE®, CARDIONOVUM’s innovative paclitaxel-coated balloon for coronary applications has received market approval for China, making it the first drug-coated balloon (DCB) available in China to treat two indications: in-stent restenosis (ISR) and small vessel disease (SVD). The approval was given based on the impressive results from two solidly designed clinical studies in Chinese populations: RESTORE ISR CHINA and RESTORE SVD CHINA.

Learn more >>

J.C. van den Berg discusses results from the APERTO AVF study

Learn more >>

Koen Deloose discusses final results from the Reflow trial

Learn more >>

Matteo Tozzi discusses new data from the APERTO AVF study

Learn more >>

Dr. Bosier interview at LINC 2019

Learn more >>

CARDIONOVUM Press Release: RESTORE® Drug-Coated Balloon Matches Zotarolimus-Eluting Stent in Patients with Coronary Small Vessel Lesions

Learn more >>

Upcoming events

Currently there are no events.

Latest events

Cardionovum at CIRSE

Cardionovum participates at CIRSE 2018

Date: Sep 22, 2018–Sep 26, 2018

Location: Lisbon, Portugal

Visit website >>

Cardionovum at EuroPCR

Cardionovum participates at EuroPCR 2018
You are welcome to visit us at booth no. M 47 (level 2)

Date: May 22, 2018–May 26, 2018

Location: Paris, France

Learn more >>

Visit website >>

Cardionovum at CLIC 2018

Cardionovum participates at CLIC 2018

Date: Mar 22, 2018–Mar 24, 2018

Location: Mestre, Italy

Learn more >>

Visit website >>

go top